"";"x"
"1";"siNT"
"2";"treated"
"3";"VEGF"
"4";"control"
"5";"TNF exposure prior to Bru labeling"
"6";"primary PSCs from cancer patient"
"7";"PR infected"
"8";"PR infected + Progesterone"
"9";"arsenite"
"10";"IFN-g"
"11";"LPS"
"12";"Agonist"
"13";"Antagonist"
"14";"Transformed to Mesenchymal Phenotype"
"15";"CPT exposure"
"16";"camptothecin"
"17";"Isoginkgetin"
"18";"WTAP overexpressed"
"19";"WTAP deficient"
"20";"normal ES cells"
"21";"Dexamethasone"
"22";"Albuterol"
"23";"Albuterol_Dexamethasone"
"24";"ATRA"
"25";"Progesterone"
"26";"Estradiol"
"27";"GD"
"28";"NGD"
"29";"ERG overexpression"
"30";"trastuzumab"
"31";"input"
"32";"IPL"
"33";"hypoxia"
"34";"flagellin"
"35";"DHT"
"36";"wild type"
"37";"Combo"
"38";"NMP"
"39";"Dicer knockdown"
"40";"siBEGAIN"
"41";"siCCNK"
"42";"siNFYA"
"43";"MMS"
"44";"Sorafenib"
"45";"Sorafenib and MMS"
"46";"NULL"
"47";"stimulated with interferon gamma and LPS"
"48";"co-culture with fibroblast"
"49";"TNF"
"50";"TNF + co-culture with fibroblast"
"51";"SYKi"
"52";"FALSE"
"53";"TRUE"
"54";"stored at room temperature"
"55";"stored on ice"
"56";"cryopreserved"
"57";"Vitamin-D"
"58";"Sutent"
"59";"no ischemia"
"60";"ischemia"
"61";"infection with adenovirus with GFP"
"62";"infection with adenovirus with MEK"
"63";"infection with adenovirus with EGFR"
"64";"infection with adenovirus with MEK and EGFR"
"65";"siNS"
"66";"Normaxia"
"67";"adipogenic stimulation"
"68";"shRARs"
"69";"sham"
"70";"0 tofacitinib"
"71";"cabozantinib"
"72";"shGFP"
"73";"shEWS-FLI"
"74";"cells were transfected with siNCAPG"
"75";"decitabine treatment"
"76";"retinoic acid"
"77";"non-infected"
"78";"H. pylori infection"
"79";"Agarose alone"
"80";"siCTCF"
"81";"doxycycline induced"
"82";"not sorted"
"83";"FACS sorted"
"84";"lactose-grown B. breve"
"85";"glucose-grown B. breve"
"86";"HMO-grown B. breve"
"87";"Lytic reactivation"
"88";"estradiol stimulation"
"89";"hormone-starved"
"90";"BenSer"
"91";"BRAFi"
"92";"BRAFi+MEKi"
"93";"CEBPA induction"
"94";"treated with erlotinib"
"95";"infected with vector expressing IkB-alpha super-repressor & treated with erlotinib"
"96";"VPA"
"97";"NT  (uninduced)"
"98";"DAPT"
"99";"post-treatment Vemurafenib"
"100";"no AlkB-derived enzyme mixture"
"101";"AlkB-derived enzyme mixture"
"102";"plus Shld"
"103";"minus Shld"
"104";"Treatment with normal pancreas exosomes"
"105";"dox-treated"
"106";"Retinoic Acid"
"107";"doxycyclin EGF"
"108";"doxycyclin"
"109";"treated with ADM"
"110";"treated with PTX"
"111";"-"
"112";"+"
"113";"Enzalutamide-Treated"
"114";"DHT: CSM"
"115";"Enzalutamide-Treated:CSM"
"116";"Hypoxia treated"
"117";"Cytokine treated"
"118";"sodium arsenite"
"119";"gemcitabine"
"120";"oil"
"121";"MeOH"
"122";"SSA"
"123";"mig"
"124";"mig_highDBZ"
"125";"highDBZ_ICN"
"126";"CHX"
"127";"PDGF-BB"
"128";"Doxycycline treated"
"129";"undifferentiated"
"130";"NTC"
"131";"To induce heat stress"
"132";"Isotype SP"
"133";"Isotype PBMC"
"134";"Isotype PBMC+SP"
"135";"Veh"
"136";"doxycycline"
"137";"AdV-GFP"
"138";"starvation"
"139";"Cntrl"
"140";"DAC"
"141";"Depsi"
"142";"DAC+Depsi"
"143";"Tetra-Pt(bpy)-treated"
"144";"No stimulation"
"145";"Serum-starved"
"146";"Doxorubicin"
"147";"vemurafenib"
"148";"CMV-RORC"
"149";"n/a"
"150";"Dox"
"151";"on-treatment"
"152";"resistant"
"153";"DOX"
"154";"Gefitinib"
"155";"respondin"
"156";"SB"
"157";"CCCP"
"158";"RPMI"
"159";"TCDD"
"160";"shHIRA"
"161";"scrambled nucleotides (Scramble G)"
"162";"Entinostat"
"163";"Vitamin C"
"164";"RA-NBM"
"165";"W"
"166";"A"
"167";"Pembrolizumab"
"168";"Ethanol"
"169";"Rapamycin"
"170";"LET"
"171";"NORAD plasmid"
"172";"Campothecin"
"173";"gene editing"
"174";"Not treated"
"175";"Cells following treatment with Decitabine"
"176";"sham-irradiated"
"177";"irradiated"
"178";"ethanol"
"179";"Nutlin"
"180";"CNT"
"181";"IFNgTNFa"
"182";"shENL Knock Down"
"183";"Gefitinib Treated"
"184";"primary tissue"
"185";"Doxyciclin"
"186";"Crizotinib"
"187";"SAHA"
"188";"DACSB"
"189";"clofarabine treated"
"190";"Certinib"
"191";"Certinib + Panobinostat"
"192";"Trametinib"
"193";"Cobalt"
"194";"Cobalt + ACF"
"195";"KHCB"
"196";"shLuciferase"
"197";"siCNTR"
"198";"VCR & Cyclo treatment"
"199";"ICG"
"200";"static culture (ST)"
"201";"treated with Dox to induce knockdown"
"202";"melphalan"
"203";"0 day"
"204";"TRCN0000000000"
"205";"ENL knockdown"
"206";"EBOV"
"207";"RESTV"
"208";"EBOV/LPS"
"209";"RESTV/LPS"
"210";"C. concisus BAA infection"
"211";"exposure to zonula occludens toxin"
"212";"C. concisus UNSWCD infection"
"213";"shMYCN"
"214";"Thapsigargin"
"215";"Trimethoprim (TMP)"
"216";"scrambled"
"217";"DHEA"
"218";"IR"
"219";"before"
"220";"after"
"221";"PMA + ionomycin"
"222";"Doxycycline"
"223";"no UVR"
"224";"UVR"
"225";"Doxycyline"
"226";"UVC-treated"
"227";"INN-treatment"
"228";"before FACS"
"229";"after FACS"
"230";"AZA"
"231";"Crenolanib"
"232";"Crenolanib + AZA"
"233";"Cisshock"
"234";"Dox treated"
"235";"Long isoform knockdown"
"236";"Both knockdown"
"237";"Short isoform knockdown"
"238";"Pravastatin"
"239";"CPT"
"240";"DRB"
"241";"Meayamycin"
"242";"Flavopiridol"
"243";"TBBz"
"244";"TBCA"
"245";"Tunicamycin"
"246";"Macrophages"
"247";"BG trained Macrophages"
"248";"Fumarate trained Macrophages"
"249";"intravenous LPS"
"250";"LPA-Treated"
"251";"-Doxycycline"
"252";"+Doxycycline"
"253";"UV-C"
"254";"nes-fto vector transfected"
"255";"testosterone pellets implated in male NOD/SCID mice"
"256";"surgical castration in male NOD/SCID mice"
"257";"testosterone pellets implated in male NOD/SCID-Î³ mice"
"258";"surgical castration in male NOD/SCID-Î³ mice"
"259";"TGFb"
"260";"GFP Overexpression"
"261";"siCon"
"262";"Rat hippocampal neurons"
"263";"AQ"
"264";"HH"
"265";"IFN"
"266";"Emetine"
"267";"Estrogen"
"268";"TAP"
"269";"CIP"
"270";"oxpapc"
"271";"tnfa"
"272";"siCEBPD"
"273";"siERG"
"274";"siSCR"
"275";"BCG"
"276";"UVC irradiated"
"277";"TNFa"
"278";"Poly I:C"
"279";"M tri-DAP"
"280";"PARP knockdown"
"281";"lapatinib"
"282";"MTX (methotrexate)"
"283";"peptide"
"284";"peptide/oligonucleotide"
"285";"dihydrotestosterone  (DHT)"
"286";"-DOX"
"287";"+DOX"
"288";"PAM"
"289";"undiff"
"290";"EGF"
"291";"estrogen"
"292";"estrogen+MPA"
"293";"micrococcal nuclease only"
"294";"pIC"
"295";"SP"
"296";"TPL"
"297";"in vitro cultured in the presence of pool of ACLF serum"
"298";"in vitro cultured in the presence of pool of normal human serum"
"299";"ZIKV Infected"
"300";"Oleic Acid"
"301";"lacZ"
"302";"IgM"
"303";"ZIKV"
"304";"cold"
"305";"shAR-FL"
"306";"shZFX"
"307";"MYBMIM peptide"
"308";"budesonide"
"309";"DEX"
"310";"siFFL"
"311";"siLuc"
"312";"siPNPase"
"313";"human Fc immobilization"
"314";"TNF stimulated"
"315";"linc-ADAL KD"
"316";"0 Î¼M BEZ + 0 Î¼M SAHA"
"317";"disulfiram"
"318";"shScramble"
"319";"shMYC"
"320";"CRISPR KO of GYPA in HEL cells"
"321";"CRISPR NTC in HEL cells"
"322";"CAF-CM"
"323";"TGF-beta"
"324";"phage PNM lysate stimulated"
"325";"Fib + TNF"
"326";"Fib + TNF + Aur"
"327";"Fib + TNF + Dex"
"328";"Fib + TNF + Tofa"
"329";"TNF + Aur"
"330";"TNF + Dex"
"331";"TNF + Tofa"
"332";"Fib + TNF + Hydrox"
"333";"Fib + TNF + Meth"
"334";"Fib + TNF + Sulf"
"335";"Fib + TNF + Triple"
"336";"TNF + Hydrox"
"337";"TNF + Meth"
"338";"TNF + Sulf"
"339";"TNF + Triple"
"340";"Fib + TNF + Diclo"
"341";"TNF + Diclo"
"342";"TNF + AG"
"343";"TNF + tofa"
"344";"Fib + TNF + AG"
"345";"Fib + TNF + hydrox"
"346";"Fib + TNF + meth"
"347";"Fib + TNF + tofa"
"348";"Wild type"
"349";"rho0"
"350";"Wild type+CCCP"
"351";"Treated with TGF-beta"
"352";"TPA"
"353";"TGFB withdrawl"
"354";"GSI"
"355";"GSI-washout"
"356";"Uninduced"
"357";"Induced"
"358";"Induced; ATMi"
"359";"plus"
"360";"minus"
"361";"non-targeting CRISPRi"
"362";"PD - pulldown"
"363";"TMZ"
"364";"no_doxorubicin_treatment"
"365";"doxorubicin_washout"
"366";"IFN-gamma"
"367";"IFN-Î³"
"368";"RA-NBM differentiated cells"
"369";"IA"
"370";"Genome Editing"
"371";"Gene Overexpression"
"372";"TGFbeta"
"373";"PolyI:C"
"374";"Etoposide"
"375";"Activin A"
"376";"ChIR"
"377";"HCMV-infected"
"378";"Progesterone+Tamoxifen"
"379";"MPA"
"380";"MPA+Tamoxifen"
"381";"Tamoxifen"
"382";"estradiol"
"383";"GFP Knockdown"
"384";"LAC-Z Knockdown"
"385";"--"
"386";"cisplatin"
"387";"doxorubicin"
"388";"Osteogenic induction"
"389";"WT"
"390";"Ang"
"391";"For"
"392";"AZA + RA"
"393";"RA"
"394";"shikonin 0 Î¼M"
"395";"Lentivirus transduction with GFP"
"396";"AKTi"
"397";"+CHIR"
"398";"-CHIR"
"399";"normoxy"
"400";"stimulation with live E. coli"
"401";"stimulation with live S. epidermidis"
"402";"tunicamycin"
"403";"DMS"
"404";"post-guadecitabine"
"405";"imatinib"
"406";"treated with hydroxyurea and nocodazole"
"407";"Serum"
"408";"Serum free"
"409";"bza"
"410";"metformin"
"411";"ssUVR"
"412";"treated with V. cholerae membrane vesicles"
"413";"treated with E. coli membrane vesicles"
"414";"Volasertib"
"415";"BETi resistant cells"
"416";"saline"
"417";"DBZ"
"418";"RTSS+RTSS+RTSS"
"419";"veh"
"420";"FTO inhibition"
"421";"exvivo"
"422";"transfection"
"423";"Activin"
"424";"Inv_SC"
"425";"silencer_SC"
"426";"anti-oxidant CAT-SKL"
"427";"TNF treatment 0h"
"428";"Bacillus Calmette-GuÃ©rin (BCG) vaccine"
"429";"LPS and Embelin"
"430";"LPS and Embelin and antagonist"
"431";"Hypoxia"
"432";"Scrambled + HP treatment"
"433";"IFNB"
"434";"IFNL"
"435";"proliferative fibroblast"
"436";"APH treated"
"437";"Enriched"
"438";"Post-CCB"
"439";"nutlin"
"440";"Primed"
"441";"Wnt-i"
"442";"- doxycycline"
"443";"+ doxycycline"
"444";"Lyophilized"
"445";"VEH"
"446";"Calcitriol"
"447";"Calcitriol + Poly I:C"
"448";"PDLSCs cultured with osteogenic induction for seven days"
"449";"shNC"
"450";"sucrose"
"451";"sucrose+AMP+DNM"
"452";"serum starved"
"453";"EGF-activated"
"454";"M-CSF"
"455";"transfected with RSLP library"
"456";"SG"
"457";"TNFSG"
"458";"Myeloma IgE-treated"
"459";"Myeloma IgE and anti-IgE treated"
"460";"treated with Cu"
"461";"insulin"
"462";"paclitaxel"
"463";"Oestradiol"
"464";"JQMT"
"465";"MTX"
"466";"shMTHBRD"
"467";"shPLKO"
"468";"Dual inhibition"
"469";"WME"
"470";"fresh isolated"
"471";"DMKG"
"472";"Rita"
"473";"RfxCasR NT array"
"474";"pU/UC"
"475";"TNF-Î±"
"476";"NBT"
"477";"exposed to CsA"
"478";"GSI inhibitor"
"479";"TBOEP"
"480";"Ruxolitinib"
"481";"CS-Oral"
"482";"CS-IV"
"483";"Atmospheric oxygen"
"484";"TCEP"
"485";"TCIPP"
"486";"Doxycycline Minus"
"487";"Doxycycline Plus"
"488";"SP treatment"
"489";"Vegf treated"
"490";"Interferon Î³"
"491";"Crizotinib + Hepatocyte growth factor (HGF)"
"492";"Crizotinib +HGF"
"493";"Hepatocyte growth factor (HGF)"
"494";"in vitro with VMAPRTLFL-pulsed target cells"
"495";"Th0"
"496";"CpGA"
"497";"N/A"
"498";"Salt Exposure"
"499";"Transfection"
"500";"Dex"
"501";"human neuron"
"502";"Post"
"503";"DUB inhibitor"
"504";"SRC stimulator"
"505";"Palbociclib"
"506";"GSK"
"507";"Mycobacterium tuberculosis infected"
"508";"entinostat"
"509";"CORIN"
"510";"estrogen withdrawal"
"511";"TGF-alpha"
"512";"co-cultured with cell line OVISE"
"513";"co-cultured with cell line OVKATE"
"514";"Chip"
"515";"Chip + BMEC"
"516";"Enza"
"517";"siAR"
"518";"treated with Vorinostat"
"519";"pre-Vorinostat"
"520";"post-Vorinostat"
"521";"si-PARN"
"522";"post-ADT"
"523";"pre-ADT"
"524";"pLOC RFP"
"525";"PPT"
"526";"PPT+MPP"
"527";"viral therapy"
"528";"radiotherapy"
"529";"Chemotherapy"
"530";"double treatment chemotherapy - viral therapy"
"531";"triple treatment chemotherapy - viral therapy - radiotherapy"
"532";"DFMO"
"533";"Dox+"
"534";"eosinophil-derived neurotoxin (EDN)"
"535";"SAHA-treated"
"536";"TCR-treated"
"537";"single dose of oral prednisone"
"538";"Eltrombopag"
"539";"serum starvation + EGF treatment"
"540";"serum starvation"
"541";"hTERT+"
"542";"BET-inhibitor"
"543";"Anti-androgen"
"544";"HEM"
"545";"pan-ERBB inhibitor neratinib (Ner)"
"546";"Ner + Ful"
"547";"RAD + Ful"
"548";"RAD + Ner"
"549";"RAD + Ner + Ful"
"550";"APAP treated"
"551";"Active"
"552";"Tunica"
"553";"group A"
"554";"group B"
"555";"CHIR + NOG"
"556";"DPN"
"557";"non-IR"
"558";"Exposure to Torkinib"
"559";"Exposure to low dose homoyessotoxin"
"560";"Exposure to mid dose homoyessotoxin"
"561";"Exposure to high dose homoyessotoxin"
"562";"Exposure to low dose lab sea spray aerosols"
"563";"Exposure to mid dose lab sea spray aerosols"
"564";"Exposure to high dose lab sea spray aerosols"
"565";"No Tunicamycin(Tm)"
"566";"No Hydrogen peroxide"
"567";"shRenilla"
"568";"len"
"569";"Yes_Vegf"
"570";"No_Vegf"
"571";"si-Contol"
"572";"Transfected with an IKKe overexpressing vector"
"573";"Atorvastatin"
"574";"Lovastatin"
"575";"Simvastatin"
"576";"Fluvastatin"
"577";"aldosterone"
"578";"Transfected with a vector expressing shLuc"
"579";"cortisol"
"580";"palbociclib"
"581";"olaparib"
"582";"veliparib"
"583";"siNC"
"584";"Oleic Acid + SPE/PaPE"
"585";"cirmtuzumab"
"586";"CRISPER sgRosa"
"587";"not treated"
"588";"TNFalpha treated"
"589";"TK"
"590";"Cell culture in Primed conditions"
"591";"RMD"
"592";"OTA"
"593";"dox"
"594";"primary organoid"
"595";"exponentially growing cells"
"596";"Beta"
"597";"Lambda"
"598";"TPO_AB"
"599";"TPO"
"600";"SCF"
"601";"AB"
"602";"GFP overexpression"
"603";"siCHERP"
"604";"LEN"
"605";"paraquat"
"606";"w0"
"607";"C"
"608";"CpG-C"
"609";"Triamcinolone acetonide (TA)"
"610";"Dexamethasone (Dex)"
"611";"Prednisolone (Pred)"
"612";"Treat with digoxin"
"613";"Fulvestrant"
"614";"panobinostat"
"615";"Rosiglitazone"
"616";"exosomes treated (Exo-T)"
"617";"GLUCURONIDE"
"618";"cisplatin solvent"
"619";"Oscillatory shear stress"
"620";"Static"
"621";"PFI"
"622";"HI MTB"
"623";"NI"
"624";"Live MTB"
"625";"venetoclax and azacitidine"
"626";"GFP transfected"
"627";"transfected with GFP vector"
"628";"transfected with SUMO vector"
"629";"no LPS"
"630";"DMS with puromycin"
"631";"ISOX"
"632";"Chemical cocktail of small molecules"
"633";"Ectopic expression of transcription factors"
"634";"Actinomycin D"
"635";"CLF"
"636";"PMA"
"637";"PMA LPS-LBP"
"638";"GM-CSF"
"639";"low glucose"
"640";"0h"
"641";"Castrated"
"642";"Intact"
"643";"Panobinostat"
"644";"si-SCR"
"645";"si-Circ"
"646";"siALYREF"
"647";"IFNÎ³+TNFÎ±"
"648";"follistatin (FST)"
"649";"DHT_ENZ"
"650";"IgG"
"651";"TimeLapse chemistry"
"652";"FULV"
"653";"F. nucleatum"
"654";"no inhibitor"
"655";"BRK inhibitor"
"656";"Neo adjuvant"
"657";"Thalidomide"
"658";"Pomalidomide"
"659";"Non UV-irradiated"
"660";"UV-irradiated"
"661";"BSA"
"662";"Myogen differentiated"
"663";"tgf-beta"
"664";"LOX"
"665";"MPB"
"666";"co-culture: Human adipose cells"
"667";"PBDE"
"668";"CsA treatment"
"669";"KOSR Differentiation protocol"
"670";"PDP"
"671";"co-culture with Wild Type BMSC"
"672";"co-culture with prkcb-/- BMSC"
"673";"siNeg"
"674";"Cisplatin"
"675";"Oxaliplatin"
"676";"Doxycyclin"
"677";"Treated with  IFNy.LPS"
"678";"CAR"
"679";"UTD"
"680";"Pyrazolanthrone"
"681";"Nilotinib"
"682";"Miglitol"
"683";"Triptolide"
"684";"Homoharringtonine"
"685";"siCt"
"686";"siAxl"
"687";"pLKO"
"688";"conditioned"
"689";"Troglitazone"
"690";"GARD"
"691";"NO (pRB-)"
"692";"YES (pRB+)"
"693";"DHTicle"
"694";"POM"
"695";"IFN-gamma and POM"
"696";"UN"
"697";"CS-NC"
"698";"CS-NC-tri"
"699";"with TGF-beta treatment"
"700";"sertraline"
"701";"DAC+SB"
"702";"overexpression"
"703";"MNP"
"704";"CS"
"705";"MNP+HA"
"706";"Abatacept"
"707";"sg-EGFP"
"708";"YAP inhibitor + Activin"
"709";"cells transfected with unloaded plasmid"
"710";"P. gingivalis"
"711";"ESC stage TCDD exposure"
"712";"Fresh tumor"
"713";"TGFB"
"714";"mixed sample (non-demultiplexed)"
"715";"Lipo"
"716";"Ibrutinib plus venetoclax"
"717";"TDF"
"718";"HiPerfect reagent"
"719";"siNTC"
"720";"ATCGCGAGGACCCGTTCCGCC"
"721";"GTCGTGCTGCAGGTGAAGTG"
"722";"CCATCCTTCAGAGTAAACAG"
"723";"shTDG"
"724";"Normoglycemia"
"725";"Hyperglycemia"
"726";"Enobosarm"
"727";"Enzalutamide"
"728";"post"
"729";"IFN alpha"
"730";"IFNbeta"
"731";"doxycycline treated cells"
"732";"not treated 0h"
"733";"SpeA"
"734";"Strep"
"735";"Unstim"
"736";"EGCG Treated"
"737";"-tet-DMS"
"738";"-tet+DMS"
"739";"+tet-DMS"
"740";"+tet+DMS"
"741";"astemizole"
"742";"+Shh+Pur"
"743";"IFN-Î² treated"
"744";"CLA"
"745";"Heat shock"
"746";"PTEN over-expressed"
"747";"PTEN knock-down"
"748";"Tetracycline"
"749";"plastic"
"750";"MDV"
"751";"IFN-Î²"
"752";"plaque extracts"
"753";"No Tamoxifen added"
"754";"Tamoxifen added"
"755";"palmitate"
"756";"palmitoleate"
"757";"palmitate and palmitoleate"
"758";"Expressing Flag-tagged wild type human ENL"
"759";"Ribociclib"
"760";"Abemaciclib"
"761";"Alvocidib"
"762";"E-cig liquid"
"763";"si knockdown non-target"
"764";"Fmoc-leu"
"765";"Cytochalasin"
"766";"Biperiden"
"767";"Putrescine"
"768";"Interferon-beta"
"769";"Carpesium cernuum extract (CCE)"
"770";"scramble mimic"
"771";"transdifferentiation to dopaminergic neuron induced by ANLmp"
"772";"HA"
"773";"d0 dox"
"774";"ReN cells + iMG"
"775";"ReN cells"
"776";"iMG"
"777";"iMG+cholesterol"
"778";"iPS"
"779";"DHA"
"780";"Rituximab"
"781";"PNK"
"782";"DEC"
"783";"Ivermectin"
"784";"Kinetin treated"
"785";"transfected with random sequence ASO"
"786";"Cycloheximide"
"787";"vector -DOX"
"788";"vector +DOX"
"789";"Water"
"790";"E. coli"
"791";"IFN-y"
"792";"foretinib"
"793";"TKI"
"794";"TKI+GSI"
"795";"Roflumilast N-oxide (RNO)"
"796";"Olaparib - treated"
"797";"Palbociclib - treated"
"798";"Ola/PD - treated"
"799";"interferon gamma"
"800";"flagelin"
"801";"shFF"
"802";"Endoderm"
"803";"Mesoderm"
"804";"Trophectoderm"
"805";"Apigenin"
"806";"Luteolin"
"807";"Gemcitabine treated"
"808";"TNF-alpha + TGF-beta"
"809";"TAM"
"810";"Neural induction -dox D"
"811";"Neural induction +dox D"
"812";"amyloid-beta"
"813";"FLA-ST Ultrapure"
"814";"IFNg"
"815";"cultured with EVs from senescent stromal cells"
"816";"dasatinib"
"817";"TamR as a reference"
"818";"Acetone"
"819";"Benzo[a]pyrene"
"820";"Dibenzo[def"
"821";"no exposure"
"822";"Cyclophosphamide"
"823";"neratinib"
"824";"0h TNFÎ±"
"825";"DEF"
"826";"LPS+DEF"
"827";"glutamine deprivation"
"828";"FOLFOX"
"829";"RKIP overexpression"
"830";"oxaliplatin"
"831";"saracatinib"
"832";"Valproic acid"
"833";"lentiviral transduction"
"834";"transduction enhancer"
"835";"transduction enhancer +lentiviral transduction"
"836";"lipofectamine"
"837";"shluc"
"838";"thapsigargin"
"839";"niacin"
"840";"no stress"
"841";"GEnC derived EVs"
"842";"dox induced lytic activation"
"843";"C(cytokines"
"844";"TC(beads+cytokines)"
"845";"busulfan"
"846";"busulfan/cyclophosphamide"
"847";"pBabe"
"848";"Thioguanine (Selleck"
"849";"Aspirin"
"850";"S/Da/De/F (SDDF)"
"851";"combo"
"852";"ars"
"853";"palbo"
"854";"Normal skin"
"855";"Replicative exhaustion"
"856";"Proliferating cells"
"857";"Dox and auxin treated"
"858";"Palbo"
"859";"BSL"
"860";"Non-targeted CRISPR cell line"
"861";"tagraxofusp"
"862";"PARPi + doxycycline"
"863";"TAT-Scrambled"
"864";"estrogen + thyroid hormone"
"865";"estrogen + tamoxifen"
"866";"estrogen + thyroid hormone+tamoxifen"
"867";"RNP"
"868";"ssODN"
"869";"RNP + ssODN"
"870";"Daunorubicin"
"871";"TFRC silencing in hela cell"
"872";"Zika virus infection"
"873";"Piperlongumine"
"874";"AEA"
"875";"bFGF"
"876";"with TMZ"
"877";"CMV"
"878";"Lapatinib"
"879";"Lapatinib plus trastuzumab"
"880";"ALK inhibitor"
"881";"SLIGRL"
"882";"ReSt"
"883";"MDA transduced with GFP particles"
"884";"Triptolide treated"
"885";"siScr"
"886";"TSA"
"887";"IFNÎ³"
"888";"STEMDIFF defintive endoderm kit"
"889";"mouse treated with cisplatin"
"890";"Pladienolide B"
"891";"EEC enrichment"
"892";"No EEC enrichment"
"893";"poyI:C stimulation"
"894";"no auxin"
"895";"auxin"
"896";"Cisplatin-treated"
"897";"APC treatment"
"898";"Universal Type I IFN alpha treatment"
"899";"IFN gamma treatment"
"900";"Interferon-alpha"
"901";"tepoxalin"
"902";"Oestrogen"
"903";"infected by ZIKV"
"904";"BisQn"
"905";"PDS"
"906";"Cells growing in culture"
"907";"flagellin-stimulated"
"908";"PNM"
"909";"BLZ"
"910";"GYY"
"911";"GYY+LPS"
"912";"LPS+GYY"
"913";"TFB-TBOA"
"914";"before cytokine exposure"
"915";"after cytokine exposure"
"916";"not_treated"
"917";"TNFalpha_treated"
"918";"dexamethasone (Dex)"
"919";"Glimepiride"
"920";"Empagliflozin"
"921";"Doxorubicin (Doxo)"
"922";"Doxorubicin + Cytarabine (Doxo+Cyta)"
"923";"Doxorubicin + Cytarabine + Decitabine (Doxo+Cyta+DAC)"
"924";"HDL"
"925";"transfected with si-NC"
"926";"thioacetamide-S-oxide"
"927";"Overexpressed with EGFP"
"928";"estradiol + ketamine"
"929";"ketamine"
"930";"Ato"
"931";"Non"
"932";"Flu"
"933";"Ros"
"934";"Sim"
"935";"NC"
"936";"proteasome inhibitor-resistant cell-derived exosomes"
"937";"phenol-red free SFM"
"938";"oligomycin"
"939";"no silencing and no TGF-Î² stimulation"
"940";"cAMO"
"941";"BMS"
"942";"air"
"943";"Pool A"
"944";"Pool C"
"945";"Taxol"
"946";"IFN-alpha treated"
"947";"Epithelium alone"
"948";"Treatment M-CSF"
"949";"Treatment GM-CSF"
"950";"Fugene treatment"
"951";"siTERT transfection"
"952";"Matrigel GFR"
"953";"collagen I-coated plates (BD Biosciences)"
"954";"infected with L. pneumophila isogenic mutant AnkH"
"955";"etoposide"
"956";"BK polyomavirus (BKPyV)"
"957";"JC polyomavirus (JCPyV)"
"958";"methylparaben"
"959";"Aspirin treated"
"960";"Ticagrelor treated"
"961";"Red blood cell lysis buffer treated"
"962";"Clopidogrel treated"
"963";"Tirofiban treated"
"964";"Cilostazol treated"
"965";"Integrilin treated"
"966";"CTX"
"967";"Freshly isolated cells"
"968";"0 hour"
"969";"shLUC condition with LPS treatment in differentiated macrophages"
"970";"PA supplementation"
"971";"TAT-Scr"
"972";"enriched"
"973";"Bortezomib"
"974";"Bortezomib+SAHA"
"975";"Doxycycline-induced-nuclear-localised-Beta-catenin"
"976";"VECTOR"
"977";"Low"
"978";"High"
"979";"TGF-Î²"
"980";"uninduced"
"981";"Fulvestrant (ICI)"
"982";"Copanlisib"
"983";"F. alocis"
"984";"Chidamide"
"985";"Solvent"
"986";"Mithramycin"
"987";"ABEmax"
"988";"Target-AID"
"989";"SpACE"
"990";"GFP"
"991";"Thioguanine(Selleck"
"992";"Fibronectin"
"993";"Secukinumab"
"994";"cetuximab"
"995";"in"
"996";"ip"
"997";"non-transduced"
"998";"dimethylfumarate"
"999";"triptolide"
"1000";"CT0.0"
"1001";"cells cultured with serum from AD patients"
"1002";"cucurbitacin C"
"1003";"shREST"
"1004";"STARVE"
"1005";"Scramble"
"1006";"Rictor"
"1007";"low passage"
"1008";"high passage"
"1009";"0 hours"
"1010";"NC-0"
"1011";"Gentamicin"
"1012";"Paromomycin"
"1013";"Neomycin"
"1014";"Tobramycin"
"1015";"Amikacin"
"1016";"Amikcain"
"1017";"With auxin"
"1018";"No auxin"
"1019";"osimertinib + trametinib"
"1020";"treated (yDox) with doxycycline"
"1021";"docetaxel"
"1022";"Acute Trametinib"
"1023";"Chronic Trametinib"
"1024";"OGT inhibitor"
"1025";"NDMA"
"1026";"ESP"
"1027";"NDMA+ESP"
"1028";"Gamma Secretase Inhibitor"
"1029";"CTCF si KD"
"1030";"Babao Dan treatment"
"1031";"unirradiated"
"1032";"arsenite treated"
"1033";"unstressed"
"1034";"depolarized"
"1035";"HRV"
"1036";"HRV_orkambi"
"1037";"HRV_ivacaftor"
"1038";"Selumetinib"
"1039";"non-silencing"
"1040";"PMA stimulation"
"1041";"SLE patient"
"1042";"BD"
"1043";"MTA"
"1044";"TC"
"1045";"sorafenib"
"1046";"dipyridamole"
"1047";"sorafenib and dipyridamole"
"1048";"DEAB"
"1049";"Retinol"
"1050";"Tofacitinib"
"1051";"Cells were treated with increasing doses of the small molecule inhibitors abexinostat"
"1052";"Methotrexate-Lactoferrin"
"1053";"Lactoferrin"
"1054";"Methotrexate"
"1055";"cocultured with PMN-MDSCs"
"1056";"PDGF"
"1057";"ASC-CM"
"1058";"Pimasertib"
"1059";"High glutamine diet"
"1060";"DOX+"
"1061";"Mycobacterium abscessus microparticle"
"1062";"Temozlomide"
"1063";"LTA"
"1064";"interferon alpha"
"1065";"RA and SAG"
"1066";"CEBPA"
"1067";"CEBPA+auxin"
"1068";"induced cells"
"1069";"non-induced cells from donors"
"1070";"osimertinib"
"1071";"vehiicle"
"1072";"erlotinib"
"1073";"gefitinib"
"1074";"dacomitinib"
"1075";"Metformin"
"1076";"FFX"
"1077";"Smoke"
"1078";"a-amanitin"
"1079";"ascorbic acid"
"1080";"Cerdulatinib"
"1081";"siScrambled"
"1082";"Denosumab"
"1083";"iron treatment"
"1084";"GI"
"1085";"GII"
"1086";"GI+TCDD"
"1087";"GII+TCDD"
"1088";"Merbarone"
"1089";"Estrogen supplementation"
"1090";"Estrogen deprivation"
"1091";"exposed to cisplatin for 0h"
"1092";"entrained to circadian metabolic rhythms"
"1093";"ODC (regorafenib"
"1094";"ODC (vemurafenib"
"1095";"Artemether (Sigma"
"1096";"Differentiation 0 hours"
"1097";"PMA treated WT"
"1098";"CH"
"1099";"no irradiated"
"1100";"Wild type (day 0)"
"1101";"ruxolitinib"
"1102";"Scramble microPEP(Scr)"
"1103";"IngenolB"
"1104";"high GFP"
"1105";"low GFP"
"1106";"TLT"
"1107";"NSA"
"1108";"NSA+TNFa"
"1109";"DMAG"
"1110";"PMA/Ionomycin treated"
"1111";"Processed through microfluidics chip"
"1112";"Processed + DEP through microfluidics chip"
"1113";"carfilzomib (Cfz)"
"1114";"omipalisib"
"1115";"scramble"
"1116";"Auxin"
"1117";"Minus TGF-Î²"
"1118";"Plus TGF-Î²"
"1119";"ALESIA racemate"
"1120";"Treated with Anti-retroviral"
"1121";"INH"
"1122";"RIF"
"1123";"PZA"
"1124";"EMB"
"1125";"AMK"
"1126";"Platinum"
"1127";"Hydroxyurea"
"1128";"Zymosan"
"1129";"Normal Culture"
"1130";"standard culture conditions"
"1131";"challenge"
"1132";"dexamethasone (DEX)"
"1133";"NIST"
"1134";"Before doxycycline"
"1135";"ActD"
"1136";"bosutinib"
"1137";"alsterpaullone"
"1138";"fenbendazole"
"1139";"thiostrepton"
"1140";"chlorhexidine"
"1141";"fluvoxamine"
"1142";"niclosamide"
"1143";"mocetinostat"
"1144";"Alprostadil"
"1145";"Penfluridol"
"1146";"Cantharidin"
"1147";"MITOXANTRONE HCL"
"1148";"Niclosamide"
"1149";"Diphenyleneiodonium chloride"
"1150";"Fenbendazole"
"1151";"Evodiamine"
"1152";"Cucurbitacin I"
"1153";"Bosutinib"
"1154";"Axitinib"
"1155";"Dasatinib"
"1156";"Arcyriaflavin A"
"1157";"Regorafenib"
"1158";"Bisantrene dihydrochloride"
"1159";"Purmorphamine"
"1160";"lovastatin"
"1161";"Vegfa"
"1162";"Egf"
"1163";"Leptin"
"1164";"Dopamine"
"1165";"ACE treatment"
"1166";"Forskolin treatment"
"1167";"primed human PSCs"
"1168";"Doxorubicin treated"
"1169";"Inducible GFP Overexpression"
"1170";"extracellular vesicles (EVs)"
"1171";"Hfol"
"1172";"TNF_Hfol"
"1173";"HF"
"1174";"HF_TNF"
"1175";"standard glucose"
"1176";"high glucose"
"1177";"Saline"
"1178";"FOLFIRI"
"1179";"CMV infection"
"1180";"Resting"
"1181";"Stimulated"
"1182";"Stimulated + chemokine"
"1183";"con"
"1184";"Poly(I:C)"
"1185";"Decitabine-treated"
"1186";"Asparagine deprivation"
"1187";"hydroxyurea treatment"
"1188";"CEBPA+auxin+LPS"
"1189";"siCEBPD-Bud"
"1190";"siCEBPD-TNF"
"1191";"siCEBPD-TNFposBud"
"1192";"static cultured"
"1193";"fluid shear stress (FSS)"
"1194";"Doxycycline-treated"
"1195";"nSi treatment"
"1196";"Caso-DHT"
"1197";"Docetaxel"
"1198";"Patient-Tumor"
"1199";"Azacitidine"
"1200";"skin cells of NC"
"1201";"Nitrosopyrrolidine"
"1202";"Methyleugenol"
"1203";"Lasiocarpine"
"1204";"Amiodarone"
"1205";"Amiodarone+HPbCD"
"1206";"eribulin"
"1207";"irinotecan"
"1208";"Osimertinib"
"1209";"treated with sodium butyrate"
"1210";"treated with bufexamac"
"1211";"M-SCF"
"1212";"Interferon gamma and LPS"
"1213";"co-cultured with neutrophils"
"1214";"EV-treated"
"1215";"compensation_starvation"
"1216";"unmodified cell line"
"1217";"lentiviral construct  Ajuba  OE sequence"
"1218";"EBV infection"
"1219";"infected with Salmonella (total population)"
"1220";"infected with Salmonella (Salmonella positive cells)"
"1221";"infected with Salmonella (bystander cells)"
"1222";"treated with secretome of Salmonella infected cells"
"1223";"No RA"
"1224";"Short term effect of antiandrogen in tumor"
"1225";"Long term effect of antiandrogen in tumor"
"1226";"AFMK"
"1227";"Melatonin"
"1228";"PRO"
"1229";"PCA"
"1230";"DHA/PRO"
"1231";"DHA/PCA"
"1232";"serum_selected"
"1233";"acutely_purified"
"1234";"serum_free_cultured"
"1235";"TNFÎ±"
"1236";"PDOX"
"1237";"Clean Air"
"1238";"Formaldehyde Air"
"1239";"Avadomide"
"1240";"Durvalumab"
"1241";"Avadomide+Durvalumab"
"1242";"Nivolumab"
"1243";"Avadomide+Nivolumab"
"1244";"si-cont transfected cells"
"1245";"TS knock down"
"1246";"Sorted TS High"
"1247";"Sorted TS Low"
"1248";"IPFSCs transducted with GFP lentvirus vector"
"1249";"IPFSCs on tissue culture plastic (TCP)"
"1250";"CpG"
"1251";"TGF-Ã"
"1252";"WT cytoplasm"
"1253";"NSC"
"1254";"Gilteritinib"
"1255";"parental cells"
"1256";"Filgotinib"
"1257";"Spironolactone"
"1258";"Mycophenolic acid"
"1259";"Tamoxifen and Mefloquine"
"1260";"Tamoxifen  and Withaferin"
"1261";"Mefloquine and Withaferin"
"1262";"SWT"
"1263";"NS"
"1264";"Amisulpride"
"1265";"Risperidone"
"1266";"Aggregation"
"1267";"progesterone + ethanol"
"1268";"H-exo"
"1269";"Day0"
"1270";"BPAF"
"1271";"BPA"
"1272";"BPB"
"1273";"BPE"
"1274";"BPF"
"1275";"BPS"
"1276";"BPZ"
"1277";"Paraquat"
"1278";"MPP"
"1279";"Ziram"
"1280";"Methyl_mercury"
"1281";"TESAMORELIN"
"1282";"Dexa-treated"
"1283";"norepinephrine"
"1284";"Fingolimod"
"1285";"Pre-ADT"
"1286";"Post-ADT"
"1287";"FNF"
"1288";"treated with doxycycline"
"1289";"GLOBINClear"
"1290";"Pooled-GLOBINClear"
"1291";"MCSF"
"1292";"HU"
"1293";"with doxycycline"
"1294";"EFV"
"1295";"AHR knockdown"
"1296";"AHR overexpression"
"1297";"shPAIP"
"1298";"Treated wit INs-seq fixation method"
"1299";"Fresh"
"1300";"Substance P treatment"
"1301";"Radiotherapy"
"1302";"Hyperthermia"
"1303";"Radiotherapy and Hyperthermia"
"1304";"clarithromycin"
"1305";"warfarin"
"1306";"bardoxolone"
"1307";"ticlopidine"
"1308";"0microliter ImmunoCult"
"1309";"VP"
"1310";"abatacept"
"1311";"scramble oligos"
"1312";"Aldosterone"
"1313";"Aldosterone and Spironolactone"
"1314";"SFA treatment"
"1315";"SFE treatment"
"1316";"CpG-B"
"1317";"TNFa treated"
"1318";"GFP Ad Transfection"
"1319";"MCC"
"1320";"CBD"
"1321";"operation"
"1322";"shEV"
"1323";"luc_WT"
"1324";"Arachidonic acid"
"1325";"Oleic acid"
"1326";"TCP"
"1327";"ATRA+TCP"
"1328";"VORINOSTAT"
"1329";"PRACINOSTAT"
"1330";"isotype"
"1331";"mAb"
"1332";"motor neuron induction"
"1333";"OTA_0uM"
"1334";"treated with ActD for 0 hours"
"1335";"nucleofected with si-VWF"
"1336";"treated with CBD"
"1337";"CHAPS only"
"1338";"FACS sorted on long chain fatty acid uptake"
"1339";"Scramble + imatinib"
"1340";"Decitabine treated"
"1341";"IFNG_EGF"
"1342";"TGFB_EGF"
"1343";"HGF"
"1344";"OSM"
"1345";"surgery only"
"1346";"post surgical chemotherapy"
"1347";"stress delayed"
"1348";"Brefeldin A treated"
"1349";"pertussis antigenic challenge"
"1350";"treated with TNF for three days"
"1351";"aqua dest"
"1352";"siC"
"1353";"siKLF"
"1354";"ad.GFP transduced"
"1355";"siNegÂ "
"1356";"TGF-beta-treated"
"1357";"AAV"
"1358";"nephrectomy only"
"1359";"AdGFP"
"1360";"RocA"
"1361";"Fulv"
"1362";"Fulv+Tram"
"1363";"Fulv+Palbo"
"1364";"Fulv+Palbo+Tram"
"1365";"Corrected"
"1366";"Uncorrected"
"1367";"MCSF+GdA"
"1368";"laminin-coated chamber slide"
"1369";"Transwell"
"1370";"PCL"
"1371";"Soy"
"1372";"ebastine"
"1373";"Val-boroPro"
"1374";"siBeta-catenin"
"1375";"treated with azathioprine"
"1376";"HIV-infected"
"1377";"HIV-infected ART-treated"
"1378";"Tcells"
"1379";"IFNgamma"
"1380";"Lomustine"
"1381";"TCPS"
"1382";"GEL"
"1383";"Forskolin"
"1384";"Treated with RA and SAG"
"1385";"radical cystectomy"
"1386";"PANO"
"1387";"TRAM"
"1388";"vector"
"1389";"sh-PML/RARa"
"1390";"Ribodepletion"
"1391";"oxLDL"
"1392";"REPSOX"
"1393";"BMP"
"1394";"BMP+Dox"
"1395";"low-dose decitabine"
"1396";"EBV-WT infected"
"1397";"w/o BK polyomavirus (BKPyV)"
"1398";"with BKPyV (Dunlop strain"
"1399";"HCQ"
"1400";"Remdesivir"
"1401";"cells transfected by shCTCLl lentivirus"
"1402";"pre-stimulation"
"1403";"post-stimulation"
"1404";"Non-hormone treated"
"1405";"Decitabine"
"1406";"BETi"
"1407";"Interferon"
"1408";"IFN-a"
"1409";"siAdar"
"1410";"Platelets"
"1411";"D+T"
"1412";"G+T"
"1413";"S+T"
"1414";"S. aureus SEB"
"1415";"shCONT"
"1416";"treated with doxycycline (Dox)"
"1417";"CEA-TCB (cibisatamab)"
"1418";"Doxicycline"
"1419";"post-treatment"
"1420";"UT-H (uremic toxin mixture)"
"1421";"Treatment with lysates of RBC infected with P. falciparum (iRBC)"
"1422";"Benz[a]anthracene"
"1423";"CAR T treatment by DNMTi inhibitor"
"1424";"CAR T treatment by DNMTi inhibitor coculture with Raij"
"1425";"unmanipulated skin"
"1426";"Extract Treatment"
"1427";"Knock out  of WWOX"
"1428";"JAM-C"
"1429";"scramble treated"
"1430";"bleomycin"
"1431";"bleomycin/grape seed extract"
"1432";"zinc apical treat"
"1433";"zinc basal treat"
"1434";"Cultured with BCSC CM"
"1435";"four days after the withdrawal of dox"
"1436";"oxamate"
"1437";"COMBO"
"1438";"Vector"
"1439";"DEG"
"1440";"TEAD inhibitor protein (TEADi)"
"1441";"Palmitate"
"1442";"ev"
"1443";"TM"
"1444";"After Mifepristone treatment"
"1445";"before Mifepristone treatment"
"1446";"Infected with Legionella Pneumophila Corby Wild Type"
"1447";"Infected with Legionella Pneumophila Corby Flagellin Deficient"
"1448";"abemaciclib"
"1449";"scrambled ASO"
"1450";"conditioned by HBMEC"
"1451";"sgROSA"
"1452";"GFP adenovirus"
"1453";"doxorubicin treatment"
"1454";"ODN"
"1455";"Primary Cells"
"1456";"Puromycin"
"1457";"Recovery"
"1458";"Basal"
"1459";"dnCRTC"
"1460";"Ricolinostat"
"1461";"Steady state"
"1462";"MitoTEMPO"
"1463";"Piericidin"
"1464";"Piericidin+MitoTEMPO"
"1465";"Antimycin"
"1466";"Antimycin+MitoTEMPO"
"1467";"treated with MgR"
"1468";"treated with MgR and OED"
"1469";"IFN-Î±"
"1470";"Vemurafenib"
"1471";"OA"
"1472";"PA"
"1473";"Antiretroviral treatment (ART)"
"1474";"Alefacept"
"1475";"treated with prexasertib"
"1476";"HDM extract"
"1477";"Carfilzomib"
"1478";"durva.mek.braf"
"1479";"durva.mek"
"1480";"Interferon-epsilon"
"1481";"Interferon-gamma"
"1482";"Interferon-lambda"
"1483";"Dead Neurons"
"1484";"AcHERVenv-CMV-GFP infected"
"1485";"Rosmarinic acid methyl ester"
"1486";"directed differention of beta cells"
"1487";"sphere culture condition"
"1488";"survived after paclitaxel treatment"
"1489";"survived after cisplatin treatment"
"1490";"survived after doxorubicin treatment"
"1491";"Plasmid transfection"
"1492";"Fluoxetine"
"1493";"ERG knockdown"
"1494";"unperturbed cells"
"1495";"one day pre-immunization"
"1496";"before tofacitinib treatment"
"1497";"HIV-CFTR"
"1498";"HIV-GFP"
"1499";"Dex.IFN"
"1500";"UT"
"1501";"Osteogenic differentiation"
"1502";"Rapa"
"1503";"zeocin"
"1504";"noncultured"
"1505";"differentiated with GM-CSF (GM-MÃ)"
"1506";"differentiated with GM-CSF (GM-MÃ) in the presence of the antifolate pemetrexed (PMX)"
"1507";"Neoadjuvant Chemotherapy"
"1508";"Li"
"1509";"Neural Progenitor Cells (NPC)"
"1510";"Live L. plantarum-Live L. plantarum"
"1511";"Heat-killed L. plantarum-Live L. plantarum"
"1512";"Amlodipine only"
"1513";"shglinc+shc-myc"
"1514";"nosg+shc-myc"
"1515";"Albumin"
"1516";"hVEGF"
"1517";"0 days HCQ"
"1518";"HKCA"
"1519";"HKCA+HCQ"
"1520";"MitoTempo"
"1521";"No TF induction"
"1522";"TF induction using doxycycline"
"1523";"TF-induction using doxycycline"
"1524";"UPEC"
"1525";"TNF-a treated"
"1526";"Undergoing Bariatric surgery"
"1527";"Surgery"
"1528";"JEV infection"
"1529";"HoxLDL"
"1530";"MoxLDL"
"1531";"Negative GapmeR"
"1532";"etoposide plus cisplatin treated tumor"
"1533";"transfected with siNC"
"1534";"Methamphetamine after infection"
"1535";"Methamphetamine before and after infection"
"1536";"shCDGAP"
"1537";"Isotype"
"1538";"normal culture"
"1539";"Cryostor"
"1540";"Ciliobrevin A"
"1541";"Treated with Buffer alone"
"1542";"Treated with Lactose alone"
"1543";"AS patient-derived iPSCs"
"1544";"CRISPR-corrected version of AS patient-derived iPSCs"
"1545";"ACY"
"1546";"Transfection of siC"
"1547";"Transfection of siD"
"1548";"nontreated"
"1549";"Selinexor"
"1550";"nutlin + Selinexor"
"1551";"Belinostat"
"1552";"LCFA"
"1553";"LCFA + Rosiglitazone"
"1554";"high LCFA"
"1555";"Lactate LCFA"
"1556";"AICAR"
"1557";"AICAR LCFA"
"1558";"siYAP + siTAZ"
"1559";"Tumor Necrosis factor"
"1560";"RITA treated"
"1561";"TuD-miR-NS"
"1562";"HSA treated"
"1563";"plus serine/glycine"
"1564";"minus serine/glycine"
"1565";"pertuzumab"
"1566";"Baricitinib"
"1567";"Growth hormone"
"1568";"IFNb_Baricitinib"
"1569";"IFNb"
"1570";"IFNb_Ruxolitinib"
"1571";"ddC"
"1572";"Cisplatin pulse"
"1573";"neurosurgical removal"
"1574";"PMA induction"
"1575";"ADAR knock down"
"1576";"KHSRP knock down"
"1577";"Atovaquone"
"1578";"primary human FL cells were FACS sorted to isolate hematopoietic subpoulations"
"1579";"dabrafenib"
"1580";"Interphase and G0 treatments"
"1581";"Interphase and Mitotic treatments"
"1582";"Interphase treatment"
"1583";"Before"
"1584";"Relapsed"
"1585";"MyoD"
"1586";"MyoD + AON"
"1587";"SAL/FLU"
"1588";"FOR"
"1589";"FOR/BUD"
"1590";"Not randomized"
"1591";"POST"
"1592";"prexasertib"
"1593";"Unmanipulated Cell Line"
"1594";"Pre thalidomide"
"1595";"Post thalidomide"
"1596";"calcitriol-treated cells"
"1597";"Non-targeting hairpin"
"1598";"Hairpin targeting RON"
"1599";"TCM"
"1600";"treated with protein"
"1601";"cultured on Flat bottom for one week"
"1602";"Akti"
"1603";"freshly isolated day 0"
"1604";"EpCAM  CAR"
"1605";"EpCAM CAR T cells treated with rapamycin"
"1606";"Early"
"1607";"deferred"
"1608";"Grass pollen sublingual immunotherapy"
"1609";"siCONT treatment"
"1610";"dexamethasone"
"1611";"EV"
"1612";"EV_PA"
"1613";"lentivirus overexpressing Vector"
"1614";"methanol exposed"
"1615";"clozapine exposed"
"1616";"single culture"
"1617";"Treatment-HDACi (SAHA/Vorinostat)"
"1618";"Case"
"1619";"Parental"
"1620";"MSC Educated"
"1621";"CREBMIM peptide"
"1622";"CRYBMIM peptide"
"1623";"EGTA_Induction"
"1624";"EGTA_CPE_Inhibition"
"1625";"phenylephrine"
"1626";"treated with DOX"
"1627";"MPTD"
"1628";"alefacept"
"1629";"AngII"
"1630";"ACTH"
"1631";"Zn"
"1632";"Cd"
"1633";"cGAMP stimulation"
"1634";"transduced with GFP"
"1635";"TRAIL only"
"1636";"Post-Allergen Challenge (house dust mite)"
"1637";"Post-Allergen Challenge (cat)"
"1638";"Post-Diluent Challenge"
"1639";"T cell depleted"
"1640";"T cell present"
"1641";"Doxycycline (DOX)"
"1642";"transfection with pCDH vectors"
"1643";"PBIT"
"1644";"PDBU"
"1645";"ALI day0"
"1646";"Expansion (EM)"
"1647";"Differentiation (DM)"
"1648";"Expansion (EM) & Differentiation (DM)"
"1649";"transfected with plasmid miniCAFE only"
"1650";"transfected with plasmid S-D only"
"1651";"transfected with plasmid V-D only"
"1652";"transfected with plasmid V-WT only"
"1653";"indisulam treatment"
"1654";"Fresh frozen"
"1655";"Adherent monolayer culture"
"1656";"0 times"
"1657";"Calmidazolium"
"1658";"Fludrocortisone"
"1659";"Lisinopril"
"1660";"Losartan"
"1661";"mammary gland"
"1662";"coculture"
"1663";"monoculture"
"1664";"vemurafenib + cobimetinib"
"1665";"vemurafenib + trametinib"
"1666";"CART"
"1667";"IAV_infected_DI_treated"
"1668";"DI_treated"
"1669";"Non Transfected"
"1670";"Irradiated"
"1671";"EGFR TKI"
"1672";"PFA fixation"
"1673";"Methanol fixation"
"1674";"TACE"
"1675";"treated with Olaparib"
"1676";"before C/EBP Beta knockdown"
"1677";"after C/EBP Beta knockdown"
"1678";"post ipilimumab"
"1679";"pre ipilimumab"
"1680";"treated with particulate matter"
"1681";"BSA_ethanol"
"1682";"EPA"
"1683";"TNF-alpha"
"1684";"neoadjuvant chemoradiotherapy + atezolizumab"
"1685";"Uncultured"
"1686";"RT : radiotherapy"
"1687";"RTG : radiotherapy + gemcitabine"
"1688";"RTO : radiotherapy + olaparib"
"1689";"RTOG : radiotherapy + olaparib + gemcitabine"
"1690";"PT : proton therapy"
"1691";"PTG : proton therapy + gemcitabine"
"1692";"PTO : proton therapy + olaparib"
"1693";"PTOG : proton therapy + olaparib + gemcitabine"
"1694";"parent oral cancer cell"
"1695";"Radioresistant oral cancer cell line"
"1696";"on_treatment"
"1697";"in vitro treated with Tofacitinib"
"1698";"gSI"
"1699";"Knockdown"
"1700";"Overexpression"
"1701";"Day 0 differentiation"
"1702";"transfected with sh-NC lentivirus"
"1703";"Cyclic Tensile Strain"
"1704";"Ectopic expression of Vector"
"1705";"Ectopic expression of STING"
"1706";"adult EVs"
"1707";"fetal EVs"
"1708";"sgLuc infection"
"1709";"antibiotics"
"1710";"Tetracyline"
"1711";"diABZI"
"1712";"PXGL"
"1713";"Retroviral transduction"
"1714";"retroviral transduction"
"1715";"serum starvation-stimulation"
"1716";"Tibolone"
"1717";"Tibolone+PalmiticAcid"
"1718";"PalmiticAcid"
"1719";"HTO library"
"1720";"nodox"
"1721";"Non Silencing"
"1722";"Underexpression"
"1723";"sulfopin"
"1724";"Untransfected"
"1725";"AH"
"1726";"H"
"1727";"RH"
"1728";"LPS+IFNg"
"1729";"LPS+IFNg+TNF"
"1730";"LPS+IFNg+TNF+IgG"
"1731";"LPS+IFNg+TNF+adalimumab"
"1732";"LPS+IFNg+TNF+etanercept"
"1733";"LPS+IFNg+TNF+certolizumab"
"1734";"Not irradiated"
"1735";"siSCRM"
"1736";"static conditions"
"1737";"CFASN"
"1738";"CFASN / minus alpha-amanitin"
"1739";"CFASN / plus alpha-amanitin"
"1740";"PMA+Ionomycin"
"1741";"E.g. stimulated"
"1742";"Strain repeat"
"1743";"Strain+Treatment"
"1744";"shNT"
"1745";"CyPA stimulation"
"1746";"water"
"1747";"ASO"
"1748";"amino acid starvation"
"1749";"siHuR"
"1750";"LDHA knockdown"
"1751";"activated PBMCs"
"1752";"resting PBMCs"
"1753";"not transduced"
"1754";"Plenti-CMV-Puro-GFP transduced"
"1755";"fused"
"1756";"Treated with BDAA"
"1757";"flu-infected"
"1758";"FAC"
"1759";"transfected with vector plasmid"
"1760";"LT"
"1761";"measles virus"
"1762";"LPS-treated"
"1763";"doxycyline"
"1764";"Chikungunya virus infected cells"
"1765";"before treatment"
"1766";"solvent"
"1767";"Drg"
"1768";"tofacitinib"
"1769";"co-cultured with apoptotic Jurkat T cells"
"1770";"unknown"
"1771";"Ranolazine treated"
"1772";"Tofacitinib treated"
"1773";"UVC"
"1774";"No therapy"
"1775";"FOLFIRINOX"
"1776";"transduced with sh-NC"
"1777";"shCTCF"
"1778";"GFP-treated"
"1779";"TAD-treated"
"1780";"TMG"
"1781";"Treated with bromosporine and cobimetinib"
"1782";"decitabine treated: at 0"
"1783";"CapTS-seq workflow"
"1784";"MYC-inhibited"
"1785";"Nitazoxanide treatment"
"1786";"Lentiviral transduction"
"1787";"Elaiophylin"
"1788";"TNFa+Smac+zVAD"
"1789";"Poly (I:C) treated"
"1790";"Poly(I:C) plus thrombin treated"
"1791";"Thrombin treated"
"1792";"Ellagic acid"
"1793";"dasatinib_cabozantinib"
"1794";"Zidovudine (ZDV)"
"1795";"Benzo(a)pyrene (BaP)"
"1796";"Cyclophosphamide (CP)"
"1797";"Propyl Gallate (PG)"
"1798";"Urea"
"1799";"Eugenol (Eug)"
"1800";"Cytosine Arabinoside (AraC)"
"1801";"Cisplatin (Cisp)"
"1802";"BrdU"
"1803";"Dn-hTERT"
"1804";"IAA"
"1805";"extra tyrosine added"
"1806";"V"
"1807";"EP"
"1808";"EDHT"
"1809";"EPDHT"
"1810";"di-ABZI"
"1811";"stimulated by RANKL"
"1812";"stimulated by TYMP"
"1813";"VITC"
"1814";"Unwounded"
"1815";"Wounded"
"1816";"genomically barcoded"
"1817";"M"
"1818";"Rosiglitazone treated"
"1819";"TGF-priming"
"1820";"Acetate"
"1821";"Acetate and CATPB"
"1822";"Zinc"
"1823";"Non-targeting"
"1824";"Non-targeting + DOX"
"1825";"Downregulated ATGL + DOX"
"1826";"silence"
"1827";"Fibrils"
"1828";"MSA"
"1829";"PD"
"1830";"CIML"
"1831";"low-dose"
"1832";"BLM"
"1833";"Tegretol"
"1834";"Nitrendipine"
"1835";"atraric acid (AA)"
"1836";"mix of gemcitabine and carboplatin"
"1837";"RV"
"1838";"Exosome-treated"
"1839";"ethanol 0"
"1840";"doxycycline+MEKinhibitor"
"1841";"MEKinhibitor"
"1842";"PMA+MEKinhibitor"
"1843";"stimulated with CEF pool"
"1844";"stimulated with Influenza M peptide"
"1845";"stimulated with Influenza A peptide"
"1846";"csEV treated"
"1847";"Not transduced"
"1848";"Transduced with GFP lentiviral  vector"
"1849";"no cell"
"1850";"Paclitaxel"
"1851";"Nizatidine"
"1852";"EV-R"
"1853";"EV-poor"
"1854";"LPS+rTcpC-treated"
"1855";"rTcpC-treated"
"1856";"Untransduced"
"1857";"Infected with lentiviral construct encoding for BRAF-WT"
"1858";"sh-Con"
"1859";"sh-LCDR"
"1860";"si-NC"
"1861";"si-hnRNP K"
"1862";"progesterone"
"1863";"estrogen + progesterone"
"1864";"GFP negative"
"1865";"GFP positive"
"1866";"Testosterone Treated"
"1867";"Follistatin Treated"
"1868";"Cocktail of Myokines Treated"
"1869";"TFC Treated"
"1870";"EPZ treated"
"1871";"actinomycin D"
"1872";"Meloxicam + Filgrastim"
"1873";"Filgrastim only"
"1874";"HMGS"
"1875";"cycloheximide (CHX)"
"1876";"LASP treated"
"1877";"postreatment"
"1878";"after treatment"
"1879";"Mtb"
"1880";"TGFBeta"
"1881";"LA"
"1882";"LA+RVT"
"1883";"PGN"
"1884";"PGN+RVT"
"1885";"EGFR-CAR-T"
"1886";"IFNg/LPS stimulated (S)"
"1887";"Riluzole"
"1888";"parental cell line"
"1889";"adipogenesis at 0 day"
"1890";"NCT treated"
"1891";"untransduced"
"1892";"co-cultured with F. nucleatum"
"1893";"treated with dye+light"
"1894";"GA-treated"
"1895";"Sal-B-treated"
"1896";"forskolin"
"1897";"AP-treated"
"1898";"LPS + IFN-gamma"
"1899";"carbo"
"1900";"-SG"
"1901";"-SG carbo"
"1902";"SSP"
"1903";"SSP carbo"
"1904";"SSP -SG"
"1905";"SSP -SG carbo"
"1906";"Normal culture"
"1907";"Oligo"
"1908";"PP"
"1909";"Roten"
"1910";"CAR T-cells"
"1911";"decitabine"
"1912";"decitabine+TSA"
"1913";"ADA treatment"
"1914";"Estrogen -"
"1915";"Estrogen +"
"1916";"Non-treatment"
"1917";"unVPA"
"1918";"treated with FA"
"1919";"wounded & treated with FA"
"1920";"PALLY"
"1921";"EGFP"
"1922";"non-transfection"
"1923";"Osimertinib/dabrafenib/lapatinib"
"1924";"Cytokine alone"
"1925";"CEBPG presence"
"1926";"CEBPG knockdown"
"1927";"sgNC"
"1928";"sgAR"
"1929";"ATRA+Cfz"
"1930";"Cfz"
"1931";"Merged"
"1932";"shNS"
"1933";"rhCYGB"
"1934";"mitoxantrone (MIT)"
"1935";"erlotinib treated"
"1936";"PMA + Ionomycin"
"1937";"venetoclax"
"1938";"cytarabine"
"1939";"venetoclax plus cytarabine"
"1940";"Olaparib"
"1941";"treated with DXR for three days"
"1942";"VitaminD muinus"
"1943";"VitaminD plus"
"1944";"CSCs in the DS model"
"1945";"CSCs in the S model"
"1946";"Carmofur"
"1947";"no IAA"
"1948";"Arecoline"
"1949";"MNPA"
"1950";"Scrambled"
"1951";"MAPK and NODAL inhibitors"
"1952";"GLUCOSE"
"1953";"INSULIN"
"1954";"TNF-a"
"1955";"ROSIGLITAZONE"
"1956";"DEXAMETHASONE"
"1957";"IBMX"
"1958";"LAUROYL-L-CARNITINE"
"1959";"METFORMIN"
"1960";"ATORVASTATIN"
"1961";"ADIPONECTIN"
"1962";"LEPTIN"
"1963";"WORTMANIN"
"1964";"RETINOIC ACID"
"1965";"DECANOYL-L-CARNITINE"
"1966";"TNFa + IFNg"
"1967";"FP"
"1968";"FP + TNFa"
"1969";"FP + IFNg"
"1970";"FP + TNF + IFNg"
"1971";"Barasertib"
"1972";"no stimulation"
"1973";"Corn oil (daily)"
"1974";"shNonTargeting"
"1975";"Blood_vessel"
"1976";"DMS treated"
"1977";"alpha-amanitin treament to inhbit PolII not PolIII"
"1978";"Transwell Co-culture s with bone marrow adipocytes"
"1979";"Givinostat"
"1980";"Tubastatin A"
"1981";"heat_shock_input"
"1982";"Hypoxia_input"
"1983";"CAGE"
"1984";"sgEV"
"1985";"IgA"
"1986";"vinigrol"
"1987";"KD GFP"
"1988";"KD HERVH"
"1989";"KD CEBPB"
"1990";"KD NT"
"1991";"PDGFBB"
"1992";"co-cultured with DRG"
"1993";"Tazemetostat"
"1994";"PB"
"1995";"glucose deprivation"
"1996";"IFN-b"
"1997";"allergen challenged"
"1998";"diluent challenged"
"1999";"LPS+Nig"
"2000";"Nig"
"2001";"SEC_LPS+Nig"
"2002";"PFA fixation and Triton X permeabilization"
"2003";"dCasMINI-VPR_sgNT"
"2004";"dCasMINI-VPR_sgTet"
"2005";"NFIA KO"
"2006";"NFIX KO"
"2007";"NFIA/X DKO"
"2008";"leukemic extracellular vesicles/EVs"
"2009";"Exposed to LPS"
"2010";"treated with NVR"
"2011";"glucocorticoids"
"2012";"Ab (Ramucirumab)"
"2013";"GFOGER"
"2014";"MATRIGEL"
"2015";"REDV"
"2016";"RGD"
"2017";"siNT+ Trametinib"
"2018";"infigratinib"
"2019";"TGF"
"2020";"PRT"
"2021";"Reversine"
"2022";"siLINK-A"
"2023";"IgM IFNg"
"2024";"siY_T_SRF"
"2025";"sh-NC"
"2026";"Sh-Speptide"
"2027";"Vaccine"
"2028";"puromycin resistance"
"2029";"HGI"
"2030";"ITF"
"2031";"ITF/AZA Combined"
"2032";"NP"
"2033";"TNF alpha"
"2034";"Scr"
"2035";"SAG treated"
"2036";"lytic induction"
"2037";"Hemin"
"2038";"TGF-B stimulated"
"2039";"TGF-B stimulated and anti-IgG antibody treatment"
"2040";"no Vit A"
"2041";"aafA mutant"
"2042";"bortezomib treated"
"2043";"MKX knock out"
"2044";"Everolimus"
"2045";"MK Alicertib"
"2046";"Palbociclib+Everolimus"
"2047";"Lentivirus infection"
"2048";"Lipopolysaccharide treated"
"2049";"cultured in LiM"
"2050";"cultured in YAC"
"2051";"uncultured"
"2052";"siAJSZ"
"2053";"DCVC"
"2054";"DCVC_LPS"
"2055";"HBV-infected (ayw"
"2056";"mDA neurons differentiation protocol"
"2057";"iPSC"
"2058";"AraC=High"
"2059";"AraC=Low"
"2060";"UNSTIM"
"2061";"BIO"
"2062";"LiCl"
"2063";"EGF treated"
"2064";"TPA treated"
"2065";"PLX"
"2066";"infection"
"2067";"LPS+BCG"
"2068";"RPMI+BCG"
"2069";"orbital mixing"
"2070";"vertical mixing"
"2071";"DAMPs treatment"
"2072";"Fasting-mimicking diet"
"2073";"IFN-Î» treated"
"2074";"Vedolizumab (VDZ)"
"2075";"shSCR"
"2076";"infected with Listeria monocytogenes EGDe"
"2077";"P. gingivalis-treated"
"2078";"P. gingivalis persisters-treated"
"2079";"BRU"
"2080";"N.A."
"2081";"lithium"
"2082";"Au spherical NP"
"2083";"Au rods NP"
"2084";"Au stars NP"
"2085";"lentivirus infected for four days"
"2086";"induced pluripotent stem cells derived from adipose derived fibroblasts using pure chemical reprogramming strategy"
"2087";"selected"
"2088";"untransfected"
"2089";"IFN Alpha TreatedÂ "
"2090";"IFN Gamma TreatedÂ "
"2091";"DHT+ENZ"
"2092";"Infected wild type C. parvum"
"2093";"Infected transgenic C. parvum"
"2094";"GFP negative/bystander"
"2095";"GFP positive/infected"
"2096";"CI-HS"
"2097";"CC-HS"
"2098";"CC-HS_ACA"
"2099";"SBRT"
"2100";"SFN"
"2101";"UA"
"2102";"Benzo[a]pyren"
"2103";"Lasiocarpin"
"2104";"PFOA"
"2105";"PFOS"
"2106";"Methapyrilene HCL"
"2107";"Dasatinib+Quercetin"
"2108";"Ang II"
"2109";"XRT_plus_Metformin"
"2110";"XRT_only"
"2111";"indole"
"2112";"CAFs CM"
"2113";"SL-CAFs CM"
"2114";"MPRA Library"
"2115";"Etoposide + Rapamycin"
"2116";"BD serum"
"2117";"HC serum"
"2118";"Sterile water"
"2119";"Overexpression of SNCA"
"2120";"Overexpression of SNCA-AS"
"2121";"SenV"
"2122";"Cobalt (II) chloride"
"2123";"oxyquinoline"
"2124";"DPI"
"2125";"Dacomitinib"
"2126";"Icotinib"
"2127";"Cediranib"
"2128";"Dovitinib"
"2129";"Quizartinib"
"2130";"Bafetinib"
"2131";"Imatinib"
"2132";"Vandetanib"
"2133";"Cabozantinib"
"2134";"Afatinib"
"2135";"Sunitinib"
"2136";"Varlitinib"
"2137";"Linifanib"
"2138";"Tivantinib"
"2139";"Foretinib"
"2140";"Neratinib"
"2141";"CSE"
"2142";"TNF 0h"
"2143";"Trastuzumab"
"2144";"+dox"
"2145";"Not applicable"
"2146";"Monolayer culture"
"2147";"mommosphere culture"
"2148";"si-MCC"
"2149";"sgNEG"
"2150";"Cobimetinib"
"2151";"TNFalpha"
"2152";"ONE"
"2153";"SED"
"2154";"MICRO"
"2155";"GMQ"
"2156";"bortezomib"
"2157";"CYLD"
"2158";"MPND"
"2159";"STAMBP"
"2160";"MYC"
"2161";"UEVLD"
"2162";"KRAS"
"2163";"Lipofectamine"
"2164";"ELL"
"2165";"HGS"
"2166";"mTORi"
"2167";"Dox+CNO"
"2168";"Oligomers"
"2169";"Testosterone"
"2170";"SPT"
"2171";"Acetonylacetone"
"2172";"Acrylamide"
"2173";"AmitriptylineHCl"
"2174";"Bucillamine"
"2175";"ButylatedHA"
"2176";"Chlorpheniramine"
"2177";"Chlorpromazine"
"2178";"Cyclopamine"
"2179";"Digoxin"
"2180";"Ibprofen"
"2181";"LithocholicAcid"
"2182";"MethapyrileneHCl"
"2183";"Thioacetamide"
"2184";"ValproicAcid"
"2185";"VerapamilHCl"
"2186";"MAOB stable overexpressed"
"2187";"scrambled lentiviral particles"
"2188";"SQLE"
"2189";"co-culture with glioblastoma cells"
"2190";"Lipofectamin only"
"2191";"APC knockdown"
"2192";"Cultured with Staphylococcus epidermidis"
"2193";"B. fungorum LPS"
"2194";"S. marcescens LPS"
"2195";"Pre vaccine"
"2196";"Post vaccine"
"2197";"Neoadjuvant vaccine"
"2198";"Congenital cardiomyopathy; male"
"2199";"Lactate treatment"
"2200";"with neutrophil extracellular traps"
"2201";"Knockout"
"2202";"radiation and TMZ"
"2203";"lenti-EGFP"
"2204";"normal occlusal contact"
"2205";"no occlusal contact"
"2206";"Lentiviral Transduction"
"2207";"heat"
"2208";"UV treated"
"2209";"Tetracylin-treated"
"2210";"citric acid (CA)"
"2211";"NETs"
"2212";"Dox and TMP"
"2213";"Flow-through"
"2214";"stable transduction with vector"
"2215";"polyIC"
"2216";"with melatonin"
"2217";"ActA treatment"
"2218";"LCORL KD"
"2219";"experiment wt Lp-Evs"
"2220";"fulvestrant"
"2221";"elacestrant"
"2222";"LPS and IFNgemma"
"2223";"Treated (Radiotherapy)"
"2224";"Treated (Radiochemotherapy)"
"2225";"Treated (Chemotherapy)"
"2226";"Tacrolimus"
"2227";"Prednisolone"
"2228";"Sodium lauryl sulfate"
"2229";"Aciclovir"
"2230";"Benzoic acid"
"2231";"Genistein"
"2232";"Ribavirin"
"2233";"Mercuric chloride"
"2234";"Cyclosporine"
"2235";"siHJURP"
"2236";"F. nucleatum-infected"
"2237";"transfected with Vector plasmids"
"2238";"with EMF"
"2239";"palbociclib treatment"
"2240";"transplanted into rat"
"2241";"in vitro"
"2242";"stimulated with M.tb whole cell lysate"
"2243";"IFN-I"
"2244";"IFN-III"
"2245";"IFN-II"
"2246";"methionine restricted Rael cells"
"2247";"siNONO"
"2248";"ICOS"
"2249";"Treated with propranolol"
"2250";"Treated with carvedilol"
"2251";"Treated with nebivolol"
"2252";"serum deprived"
"2253";"with blank plasmid knock-down"
"2254";"mild ovarian stimulation"
"2255";"Infliximab"
"2256";"Vedolizumab"
"2257";"Adalimumab"
"2258";"Erastin"
"2259";"Erastin+Vitamin C"
"2260";"deferoxamine"
"2261";"ferric anmonium citrate"
"2262";"Calorie restriction"
"2263";"Protein restriction"
"2264";"Liposome"
"2265";"cyclic uniaxial strain"
"2266";"static culture"
"2267";"DAC-treated"
"2268";"non DAC-treated"
"2269";"Mannitol"
"2270";"Glucose"
"2271";"Fructose"
"2272";"L-arabinose"
"2273";"Tumorsphere-formation assay"
"2274";"Mepolizumab"
"2275";"parental"
"2276";"doxy+"
"2277";"HR condition with SCIRT knockdown"
"2278";"before G-CSF treatment"
"2279";"After G-CSF treatment"
"2280";"Nil"
"2281";"Dimethyl Fumarate"
"2282";"Buffer"
"2283";"Lac"
"2284";"Toxinless"
"2285";"Îagr"
"2286";"ÎcoaÎvWbp"
"2287";"ÎsaeQRS"
"2288";"ÎsrtA"
"2289";"FPR"
"2290";"S. epidermidis"
"2291";"pre-therapy"
"2292";"after isolated HFs"
"2293";"sham irradiation"
"2294";"RAP"
"2295";"ALI cultures treated with EMT"
"2296";"ALI cultures"
"2297";"submerged cultures"
"2298";"Deferoxamine treated"
"2299";"Imatinib treated"
"2300";"TTFields"
"2301";"no ActD"
"2302";"single cell - hashtag antibody"
"2303";"single cell - other antibodies"
"2304";"single cell - ORF identity"
"2305";"single cell - alpha and beta TCR"
"2306";"MGT+EV"
"2307";"Proliferative"
"2308";"Quiescent"
"2309";"acute exposure"
"2310";"chronic exposure"
"2311";"Temozolomide/Radiation"
"2312";"treated with lipofectamine"
"2313";"transfected with RFP expression vector"
"2314";"pembrolizumab and decitabine"
"2315";"verum"
"2316";"Lactate"
"2317";"iBET"
"2318";"Lactate_iBET"
"2319";"CISPLATIN"
"2320";"LURBINECTEDIN"
"2321";"Bintrafusp alfa"
"2322";"mechanical stretch"
"2323";"APG"
"2324";"Clarithromycin"
"2325";"MPP+"
"2326";"Cells treated with palbociclib"
"2327";"Nitrofurantoin (NIT)"
"2328";"Novobiocin (NOV)"
"2329";"Metronidazole (MTZ)"
"2330";"Bleomycin (BL"
"2331";"transfected with Scramble"
"2332";"Rhumatoid arthritis patient under adalumumab treatment"
"2333";"Rhumatoid arthritis patient under MTX treatment"
"2334";"siCLOCK"
"2335";"depolarization"
"2336";"Trizol"
"2337";"dihydrotestosterone"
"2338";"OPG"
"2339";"RANKL"
"2340";"LACZ knockdown"
"2341";"Indisulam"
"2342";"Palbocicilib + Indisulam"
"2343";"no vector"
"2344";"L-Alanosine (ALA)"
"2345";"diabetic cardiomyocytes modeling"
"2346";"DOX and DTX-based treatment"
"2347";"Atuveciclib"
"2348";"estrogen deprivation"
"2349";"Heated Tobacco Product"
"2350";"Paclitaxel + Regorafenib"
"2351";"Input"
"2352";"AlkB demethylase treated"
"2353";"Plated on Soft get"
"2354";"Plated on Hard gel"
"2355";"dim light"
"2356";"strong light"
"2357";"CEPT cocktail"
"2358";"STEMdiffâ¢ Definitive Endoderm Kit (STEMCELL Technologies)"
"2359";"THC"
"2360";"THC + Genistein"
"2361";"After Immunotherapy"
"2362";"During Targeted Therapy"
"2363";"After Targeted Therapy"
"2364";"During Immunotherapy"
"2365";"After multiple"
"2366";"After Chemotherapy"
"2367";"Unknown"
"2368";"CBLB-KO"
"2369";"ELDR over expressed"
"2370";"CM"
"2371";"CM - no GF"
"2372";"xfCM"
"2373";"prunetin"
"2374";"hook"
"2375";"ib"
"2376";"NRX"
"2377";"Interferon gamma"
"2378";"PRELP-treated"
"2379";"Sham treated"
"2380";"Simvastatin treated"
"2381";"TNF-alpha treated"
"2382";"WT with Dox induction"
"2383";"Jurkat-Vector with Dox induction"
"2384";"HeLa transfected with R-PE"
"2385";"PFFno"
"2386";"PFFyes"
"2387";"ENZ"
"2388";"Pacliataxel"
"2389";"Tigecycline-treated"
"2390";"not applicable"
"2391";"honokiol"
"2392";"siGCDH"
"2393";"expressing pBabe-puro and pGIPZ-NTC"
"2394";"CAR T_Bulk"
"2395";"CAR T_N/SCM"
"2396";"lactate purified"
"2397";"SADS-CoV infection"
"2398";"b-elemene"
"2399";"small molecule differentiation"
"2400";"gene knockout"
"2401";"sgLuc expression"
"2402";"ATRA treated"
"2403";"ATRA withdrawn"
"2404";"with Dox"
"2405";"High Calcium"
"2406";"Low Calcium"
"2407";"chondrogenic differentiation"
"2408";"overexpressing GFP"
"2409";"hypoxia and gemcitabine"
"2410";"Icaritin"
"2411";"co-cultured with WT"
"2412";"CRT"
"2413";"CRTL"
"2414";"Gem/abraxane"
"2415";"nivolumab"
"2416";"H. pylori wild-type"
"2417";"H. pylori htrA deletion mutant"
"2418";"No transfection"
"2419";"co-culture"
"2420";"FC-A (Fusicoccin A)"
"2421";"IFNÎ± (interferon alpha)"
"2422";"FC-A + IFNÎ± (Combi)"
"2423";"Talazoparib"
"2424";"Formoterol"
"2425";"TNFÎ± + Formoterol"
"2426";"neural crest differentiation"
"2427";"hyperoxia"
"2428";"perfusion"
"2429";"ADT"
"2430";"toyocamycin"
"2431";"castration"
"2432";"enzalutamide"
"2433";"castration + enzalutamide"
"2434";"shPKM-treated"
"2435";"enzalutamide (long-term)"
"2436";"LTenza FUCRW"
"2437";"LTenza  cMyc"
"2438";"LTenza  shScr"
"2439";"transfected - SM-opt FLuc-GFP"
"2440";"cultured with pTDM"
"2441";"macrophage differentiation"
"2442";"bevacizumab+gamma irradation"
"2443";"conv. PTX+gamma irradation"
"2444";"dd PTX+gamma irradation"
"2445";"motor neuron differentiation"
"2446";"Ipilimub+Nivolumab"
"2447";"HFn-BDC"
"2448";"HFn-Cur"
"2449";"adherent culture"
"2450";"adherent culture+TNFa"
"2451";"Knocked out HUNK"
"2452";"reattached tumor sphere cells under the same conditions as the parental cells"
"2453";"Unexposed"
"2454";"Rinse Aid"
"2455";"treated with TBHP"
"2456";"treated with TBHP + ML"
"2457";"immunosuppressive therapy"
"2458";"midbrain dopamine neuron-directed differentiation"
"2459";"TCR"
"2460";"lupeol solvent group"
"2461";"Null"
"2462";"mesoderm induction"
"2463";"Arsenic Treated"
"2464";"LrGCGC"
"2465";"Lithium"
"2466";"expesed to near zero gravity (microgravity)"
"2467";"exposed to near zero gravity (microgravity)"
"2468";"maturation culture+CDDO-Me"
"2469";"PMA/Ionomycin"
"2470";"UV exposure"
"2471";"M0"
"2472";"RABV"
"2473";"siScramble transfection"
"2474";"siBCMA transfection"
"2475";"HCMV"
"2476";"overexpressed"
"2477";"Doxycycline induced differentiation"
"2478";"osteogenic transdifferentiation"
"2479";"IFN_treated"
"2480";"EBRT treated"
"2481";"exposed to carbon black"
"2482";"Non-irradiated"
"2483";"Androgen deprivation therapy"
"2484";"CpG+IVIG"
"2485";"CpG+desialylated IVIG"
"2486";"antisense oligonucleotide"
"2487";"PD treatment"
"2488";"PAR-Clip by streptavidin resin and Flag resin"
"2489";"Ento"
"2490";"AZD"
"2491";"Ento+AZD"
"2492";"siSCR transfection"
"2493";"KSHV-infection"
"2494";"astrocyte differentiation"
"2495";"Radiation"
"2496";"EPZ"
"2497";"sh-Scramble"
"2498";"Automated"
"2499";"Suspension"
"2500";"shLuc"
"2501";"FB+/ECM+"
"2502";"shLUC"
"2503";"ITAC"
"2504";"Adherent conditions"
"2505";"Grown in suspension"
"2506";"Sh-CLOCK"
"2507";"Sh-NC"
"2508";"utomilumab"
"2509";"TOFA"
"2510";"PBO"
"2511";"+Asn"
"2512";"-Asn"
"2513";"-Asn+Fe"
"2514";"HIV"
"2515";"HIV + Methamphetamine"
"2516";"relacorilant"
"2517";"cortisol and relacorilant"
"2518";"IR-treatment"
"2519";"Quiescent Cells Differentitation"
"2520";"siNC transfected"
"2521";"Base editing"
"2522";"normal serum"
"2523";"Cells"
"2524";"histidinol"
"2525";"osteogenic differentiation (beta--glycerophosphate)"
"2526";"Acala"
"2527";"treated with overexpres FIT"
"2528";"Etomidate"
"2529";"Propofol"
"2530";"transurethral resection of the bladder tumor"
"2531";"partial cystectomy"
"2532";"laparoscopic radical cystectomy"
"2533";"null"
"2534";"PTPRK knockdown"
"2535";"nucleofection"
"2536";"Cocultured with macrophages"
"2537";"co-cultured"
"2538";"unfed"
"2539";"T0"
"2540";"iEZH"
